Biosimilars ∙ Regulatory Frameworks for Marketing Authorisation of Biosimilars: Where Do We Go From Here?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biosimilars ∙ Regulatory Frameworks for Marketing Authorisation of Biosimilars: Where Do We Go From Here?

Published:2018 Issue:3 Volume:2 Page:149-154
ISSN:2511-7157
Container-title:European Pharmaceutical Law Review
language:
Short-container-title:European Pharmaceutical Law Review

Author:

Moorkens E.,G Vulto A.,Huys I.

Publisher

Lexxion Verlag

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report;Value in Health;2023-08

2. Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars;Pharmaceuticals;2021-02-25

3. Clinical and Regulatory Concerns of Biosimilars: A Review of Literature;International Journal of Environmental Research and Public Health;2020-08-11

4. Biosimilars in Belgium: a proposal for a more competitive market;Acta Clinica Belgica;2020-05-13

5. Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!;BioDrugs;2019-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP